Skip to main content
Print Save

Manzatin-E Diaper Rash Skin Protectant

Medically reviewed by Drugs.com. Last updated on Dec 17, 2020.

Dosage form: ointment
Ingredients: ZINC OXIDE 18g in 100g
Labeler: Laboratorios Zepol S.A.
NDC Code: 55715-002

Manzatin-E Diaper Rash Skin Protectant

Active Ingredient

Zinc Oxide 18%      

Purpose

Skin Protectant

Uses

Helps treat and prevent diaper rash. Protects chafed skin due to diaper rash and helps seal out wetness.

Warnings

For external use only.

When using this product

do not get into eyes

Stop using and ask a doctor if

-condition worsens 
- symptoms last more than 7 days or clear up and occur again within a few days.

Keep out of reach of children

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Change wet and soiled diapers promptly, cleanse the diaper area and allow to dry. Apply cream liberally as often as necessary, with each diaper  change, especially at bedtime or  anytime when exposure to wet  diapers may be prolonged.

Other Information

- Store in a fresh place,
preferably below 30 degrees C (86 degrees F).

Inactive Ingredients

Chamomile Flower Extract, CodmLiver Oil, in a special protective lipoid cream base, Corn Starch,

MANZATIN-E DIAPER RASH SKIN PROTECTANT 
zinc oxide ointment
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:55715-002
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ZINC OXIDE (ZINC OXIDE) ZINC OXIDE18 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
CHAMOMILE 
COD LIVER OIL 
STARCH, CORN 
Packaging
#Item CodePackage Description
1NDC:55715-002-0290 g in 1 TUBE
2NDC:55715-002-061 TUBE in 1 BOX
2180 g in 1 TUBE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart34810/01/2009
Labeler - Laboratorios Zepol S.A. (853070985)

Document Id: 6195e63c-01f6-6c90-e053-2991aa0ae81a
Set id: cafd084f-8493-4d6e-b256-2d4b4282f866
Version: 5
Effective Time: 20171227
 
Laboratorios Zepol S.A.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer